In this issue of JAMA Otolaryngology-Head & Neck Surgery, Silver Karcioglu et al 1 report the findings of a cross-sectional survey of 1412 thyroid cancer survivors, administered between October 2019 and February 2020, through ThyCa: Thyroid Cancer Survivors' Association Inc, to its membership and visitors to its public-facing website. Participants were asked about their understanding of their treatment plan, whether treatments met their expectations, and their unmet needs relating to thyroid cancer care, using both multiple-choice and free-text questions. Overall, 1249 respondents (88.4%) were women, with a median age of 48 years (range, 18-85 years) at diagnosis and a median age of 60 years (range, 18-87 years) at survey completion. A total of 834 respondents (59.6%) reported a single surgical intervention, and 1155 (81.8%) reported receipt of radioactive iodine (RAI). Following mixed-methods analysis of the survey results, the authors found that 526 respondents (37.2%) reported inadequate understanding of their pretreatment plan and 578 (40.9%) felt that their treatment experience did not meet their expectations. Among the patients with inadequate understanding of their treatment plan, only 95 (18.1%) felt that their treatment met expectations. Clinical indicators for having unmet expectations included female sex, younger age at diagnosis, and presence of complications; however, the greatest indicator of treatment meeting expectations was a reported full understanding of the treatment plan. The most commonly reported areas contributing to the lack of pretreatment plan understanding related to postoperative treatment, surveillance, and treatment effects such as postsurgical recovery, thyroid hormone replacement, and postthyroidectomy symptoms. The study by Silver Karcioglu et al 1 adds qualitative insights to the question of how clinicians can best address concerns relating to thyroid cancer diagnosis and survivorship care to improve patient understanding and underscores the importance of setting treatment expectations from the get-go.Addressing best practices in thyroid cancer survivorship is critically important due to the rapid increase in thyroid cancer diagnoses in the US over the last half-century, with the majority being small and indolent thyroid cancers conferring excellent survival. 2 However, despite a favorable prognosis for most patients, the diagnosis of thyroid cancer has been shown to be associated with detrimental effects to health-related quality of life (HRQoL). 3 Thyroid cancer survivors experience worse HRQoL compared with the general population, which is on par with that of other, more aggressive, malignancies. 3 Observational studies have shown that worsening HRQoL among thyroid cancer survivors persists beyond initial treatments, with only marginal improvements seen over 5 years. 4 It has previously been suggested that unmet information needs may contribute to reduced HRQoL in these patients. 5 A prior survey of